Stock 688065 CATHAY BIOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Cathay Biotech Inc.

Equities

688065

CNE100004447

Specialty Chemicals

End-of-day quote Shanghai S.E.
Other stock markets
 2024-12-09 		5-day change 1st Jan Change
44.81 CNY -0.20% Intraday chart for Cathay Biotech Inc. -1.08% -18.50%
Oct. 30 Cathay Biotech Inc. Reports Earnings Results for the Nine Months Ended September 30, 2024 CI
Oct. 22 Cathay Biotech Inc. announces an Equity Buyback for CNY 20 million worth of its shares. CI

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration

Latest news about Cathay Biotech Inc.

Cathay Biotech Inc. Reports Earnings Results for the Nine Months Ended September 30, 2024 Oct. 30 CI
Cathay Biotech Inc. announces an Equity Buyback for CNY 20 million worth of its shares. Oct. 21 CI
Cathay Biotech Inc. authorizes a Buyback Plan. Oct. 20 CI
Cathay Biotech's H1 Profit Rises 2%, Revenue Jumps 40%; Shares Down 3% Aug. 15 MT
Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023. Aug. 15 CI
Cathay Biotech Inc.'s Equity Buyback announced on August 17, 2023, has closed with 977,764 shares, representing 0.17% for CNY 50.43 million. Aug. 15 CI
Cathay Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2024 Aug. 15 CI
Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023. Jul. 01 CI
Cathay Biotech Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 Apr. 29 CI
Cathay Biotech's Q1 Profit to Surge Up to 100%, Revenue to Climb 43%; Shares Up 6% Apr. 15 MT
Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023. Apr. 01 CI
Cathay Biotech's 2023 Profit Drops 34% as Revenue Falls 13% Feb. 25 MT
Cathay Biotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 Feb. 23 CI
Cathay Biotech Inc. and 3P.Com Co. Limited Signs Joint Venture Agreement to Propel Sustainable Composite Innovations Feb. 08 CI
Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023. Jan. 02 CI
Cathay Biotech Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023 23-10-30 CI
Tranche Update on Cathay Biotech Inc.'s Equity Buyback Plan announced on August 17, 2023. 23-10-09 CI
Cathay Biotech Inc.(XSSC:688065) added to S&P Global BMI Index 23-09-18 CI
Cathay Biotech Inc.(XSSC:688065) added to FTSE All-World Index 23-09-18 CI
Cathay Biotech Inc. announces an Equity Buyback for CNY 100 million worth of its shares. 23-08-17 CI
Cathay Biotech Inc. authorizes a Buyback Plan. 23-08-16 CI
Cathay Biotech Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 23-08-03 CI
Cathay Biotech Forms Business Cooperation Agreement 23-06-27 MT
HBM Healthcare's Portfolio Company Cathay Biotech to Sell Shares for CNY6.6 Billion 23-06-26 MT
Cathay Biotech Inc. announced that it expects to receive CNY 6.599999958 billion in funding 23-06-24 CI

Chart Cathay Biotech Inc.

Chart Cathay Biotech Inc.
688065: Dynamic Chart

Company Profile

Logo Cathay Biotech Inc.
Cathay Biotech Inc is a China-based company mainly engaged in the research and development, production and sales of new bio-based materials. The Company's main products include a series of bio-based long-chain dibasic acids (DC10-DC18), bio-based pentamethylenediamine and a series of bio-based polyamides. The Company's brands include Taylon mainly used in the textile field and ECOPENT mainly used in the engineering materials field. The Company's product application areas include civil silk field, industrial silk field, non-woven fabric field, engineering plastics field, and others. The Company is developing bio-based polyamide thermoplastic composite materials, which can be used in new energy equipment, transportation logistics, building decoration and other industries.
Employees
1,803
Sector
Specialty Chemicals
Calendar
2025-03-31 - Q4 2024 Earnings Release (Projected)
More about the company

Income Statement and Estimates

income-statement-evolution-chart CATHAY-BIOTECH-INC More financial data

Annual profits - Rate of surprise

quality-estimates-chart CATHAY-BIOTECH-INC Company calendar
  1. Stock Market
  2. Equities
  3. 688065 Stock
  4. News Cathay Biotech Inc.
  5. HBM Healthcare's Portfolio Company Cathay Biotech to Sell Shares for CNY6.6 Billion